Claim: Proposal for Lyme prevention included in appropriations deal.
Verdict: SUPPORTS

Retrieved passages:
title: Terry Gipson
text: provided the opportunity for the 13 surrounding municipalities to apply for state and federal funding for waterfront revitalization, storm water treatment, and wastewater management, among other projects. Gipson’s office organized a strategic campaign to make the State Senate understand the urgency of helping victims with Lyme disease. During his term, the state began the process of providing funding for research and passing laws to help the victims of Lyme and other tick-borne diseases. Gipson supported a $9 million increase to the Environmental Protection Fund and a $90 million investment in New York State Parks funding in the 2014-15 state budget.

title: Charlie Baker
text: health insurance coverage for long-term Lyme disease treatment was overridden by the state legislature. Later in the same month, Baker signed into law a bill mandating insurance coverage of treatment for HIV-associated lipodystrophy caused by older HIV medications. In December 2016, due to Baker's midyear budget cuts, Baystate Health lost $1 million in funding. In January 2017, in his state budget proposal for fiscal year 2018, Baker proposed a $2,000-per-employee assessment on businesses that do not offer health insurance to counter spending growth in MassHealth, which received opposition from the state business community and support from health care unions. In

title: Zika Authorization Plan Act of 2016
text: Congress called the Zika Response and Preparedness Appropriations Act of 2016. This bill would have amended the Public Health Service Act to reauthorize grants for state mosquito control programs through FY2020. The bill would authorize $200 million per year for each fiscal year 2016 through 2020 for grants for state mosquito programs. Specifically, the bill amended Subsection (f) of section 317S of the Public Health Service Act (42 U.S.C. 247b–21(f)) as follows: "(f) Authorization Of Appropriations.—To carry out this section, there is authorized to be appropriated $200,000,000 for each of fiscal years 2016 through 2020". The bill was introduced in

title: Zika Authorization Plan Act of 2016
text: be curbed utilizing every tool at our disposal in a coordinated international response," Clawson said. "The Zika virus is sneaking up on us and we're not paying enough attention. If we deal with it prior to an outbreak we will be much better off." At the end of 2016, the U.S. Centers for Disease Control and Prevention (CDC) awarded $184 million in funding to states, territories, local jurisdictions and universities to protect people from the spread of the Zika virus. The awards were given as a part of $350 million in funding provided to the CDC under legislation passed by

title: Infectious Diseases Society of America
text: Collaborations are formed between the regulatory bodies and pharmaceutical industry with funding and added incentives. The IDSA's prognosis for sustainable R&D infrastructure for antibiotics development will depend upon clarification of FDA regulatory clinical trial guidance which would facilitate the speedy approval of new drugs, and the appropriate economic incentives for the pharmaceuticals companies to invest in this endeavor. The IDSA recommends against long-term antibiotic treatment for Lyme disease, arguing that it is ineffective and potentially harmful. The American Academy of Neurology and National Institutes of Health similarly recommend against such treatment. However, a minority view holds that chronic Lyme disease

title: Karen Ludwig
text: Lyme disease, and in May 2016, co-chaired a national roundtable on the disease. She led a series of roundtables across the country following the national one, and supported a pilot project in her riding for increased tick surveillance. Most recently, Ludwig was joined by representatives from New Brunswick's universities, research institutions, and medicals professions at the Huntsman Marine Science Centre in St. Andrews, New Brunswick to discuss research and awareness on Lyme. On May 30, 2018, MP Ludwig called on the House of Commons Standing Committee on Health to review the spraying the controversial herbicide, glyphosate. Her request came in

title: Lyme disease
text: effective in the prevention of tick bites. In Europe known reservoirs of "Borrelia burgdorferi" were 9 small mammals, 7 medium-sized mammals and 16 species of birds (including passerines, sea-birds and pheasants). These animals seem to transmit spirochetes to ticks and thus participate in the natural circulation of B. burgdorferi in Europe. The house mouse is also suspected as well as other species of small rodents, particularly in Eastern Europe and Russia. A recombinant vaccine against Lyme disease, based on the outer surface protein A (ospA) of "B. burgdorferi", was developed by SmithKline Beecham. In clinical trials involving more than 10,000

title: Political positions of Mitt Romney
text: seniors. The Romney campaign noted that the study did not specifically model any proposal from either campaign. In September 2012, a mailer from the Romney and Ryan campaign indicated they favored a law regarding "chronic Lyme disease", a controversial and unrecognized diagnosis, that will provide "physicians with protection from lawsuits to ensure they can treat the disease with the aggressive antibiotics that are required." Asked "How will you help with the housing and foreclosure problems in the U.S.?", Romney responded that it would be best not to try and stop the foreclosure process, to let it run its course and

title: Antimicrobial resistance
text: if preventive actions are not taken. In this day and age current antimicrobial resistance leads to longer hospital stays, higher medical costs, and increased mortality. For the fiscal year 2016 budget, President Obama suggested to nearly double the amount of federal funding to "combat and prevent" antibiotic resistance to more than $1.2 billion. Many international funding agencies like USAID, DFID, SIDA and Bill & Melinda Gates Foundation have pledged money for developing strategies to counter antimicrobial resistance. Since the mid-1980s pharmaceutical companies have invested in medications for cancer or chronic disease that have greater potential to make money and have

title: Lyme disease
text: withdrawal of LYMErix as an instance in which "unfounded public fears place pressures on vaccine developers that go beyond reasonable safety considerations." The original developer of the OspA vaccine at the Max Planck Institute told "Nature": "This just shows how irrational the world can be... There was no scientific justification for the first OspA vaccine LYMErix being pulled." Vaccines have been formulated and approved for prevention of Lyme disease in dogs. Currently, three Lyme disease vaccines are available. LymeVax, formulated by Fort Dodge Laboratories, contains intact dead spirochetes which expose the host to the organism. Galaxy Lyme, Intervet-Schering-Plough's vaccine, targets

title: Sylvia Mathews Burwell
text: Development Authority splitting $152million for the domestic effort. In response to Congressional complaints that the money was not being spent fast enough, Burwell informed Congress that without further funding the CDC's funding to fight Zika would be depleted by September 30, 2016. After Burwell moved funding from other HHS programs, Congress finally appropriated $1.1billion to fight the spread of Zika in the United States. By the end of September 2016, the United States reported 23,000 cases in the territory of Puerto Rico, 3,000 cases in the states, and 21babies born in the United States with microcephaly testing positive for Zika.

title: Camp Curtis Guild
text: by the United States Coast Guard, as well for training. In 1992, the army conducted a Lyme Disease Risk Assessment and noted that the disease was present in ticks at the facility, as well as the presence of human Lyme disease cases in the surrounding area. In 1968 the site was selected to host the Boston-area Sentinel ABM, but fierce public opposition led to the project being put on hold, and then canceled in favor of the Safeguard Program, which was located far from urban areas. In 1998, the outdoor firing facility was closed after a stray bullet nearly struck

title: Lyme disease microbiology
text: the surface protein OspA (LYMErix; SmithKline Beecham) was licensed for use in adults. However, the manufacturer voluntarily removed the vaccine from the market in 2002. The current focus is on vaccine candidates that require fewer boosts and provide long-term protection. Interest is developing in vaccines that specifically target the tick vectors of Lyme disease, specifically components of tick saliva that coat the bacteria. This approach offers the advantage of protecting against multiple pathogens with one vaccine. While an effective Lyme disease vaccine seems likely to be developed, earlier experiences with the LYMErix vaccine suggest bringing such a vaccine to market

title: Tick-Borne Disease Alliance
text: host. On March 11, 2013, TBDA hosted a forum with U.S. Senators Kirsten Gillibrand (D-N.Y.), Richard Blumenthal (D-CT) and Congressman Chris Gibson (R-NY) at Weill Cornell Medical College in New York City to discuss the fight against the silent epidemic of tick-borne diseases, including Lyme disease. Gillibrand, Blumenthal, Weill Cornell Medical College's dean Dr. Laurie H. Glimcher and co-chairman of TBDA David Roth were distinguished speakers at the forum. In February 2014, TBDA merged with the Stamford-based Lyme Research Alliance to form a new charity, the Global Lyme Alliance. Tick-Borne Disease Alliance The Tick-Borne Disease Alliance (TBDA) was a US

title: Lyme disease
text: proteins OspC and OspA. The OspC antibodies kill any of the bacteria that have not been killed by the OspA antibodies. Canine Recombinant Lyme, formulated by Merial, generates antibodies against the OspA protein so a tick feeding on a vaccinated dog draws in blood full of anti-OspA antibodies, which kill the spirochetes in the tick's gut before they are transmitted to the dog. Valneva's hexavalent (OspA) protein subunit-based vaccine candidate VLA15 was granted fast track designation by the U.S. Food and Drug Administration in July 2017 which will allow further study. Attached ticks should be removed promptly, as removal within

title: Lyme disease
text: (Amitraz), phenylpyrazoles (Fipronil), or permethrin (pyrethroids). These acaricides target primarily the adult stages of Lyme-carrying ticks and reduce the number of reproductively active ticks in the environment. Formulations of these ingredients are available in a variety of topical forms, including spot-ons, sprays, powders, impregnated collars, solutions, and shampoos. Examination of a dog for ticks after being in a tick-infested area is an important precautionary measure to take in the prevention of Lyme disease. Key spots to examine include the head, neck, and ears. The National Institutes of Health have supported research into bacterial persistence. Lyme disease Lyme disease, also known

title: Chris Gibson (New York politician)
text: expanding access to broadband and better treatment of Lyme disease. He held a forum on Lyme disease in Saratoga Springs that attracted 500 people, including patients, medical experts, and environmental professionals. He has been an advocate for passage of the 2012 Farm Bill, even signing a discharge petition to bring the bill to a vote in the House. Gibson supported reauthorization of the Violence Against Women Act. On January 5, 2015, Gibson announced that he would not run for re-election in 2016. He said that he might run for statewide office in 2018, when the offices of Governor, Lieutenant Governor,

title: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
text: months since the White House asked for such legislation, includes funding to help fight the Zika virus and study its effects, such as on unborn babies. It also included help for residents of Flint, Michigan and Louisiana. The bill averted a government shutdown mere days before the funding deadline. Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act The Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act () is an appropriations bill which extended funding at the previous year's

title: Chronic Lyme disease
text: have the condition. Groups advocates and the small number of physicians who support the concept of chronic Lyme disease have organized to lobby for recognition of this diagnosis, as well as to argue for insurance coverage of long-term antibiotic therapy, which most insurers deny, as it is at odds with the guidelines of major medical organizations. In 2006, Richard Blumenthal, the Connecticut Attorney General, opened an antitrust investigation against the IDSA, accusing the IDSA Lyme disease panel of undisclosed conflicts of interest and of unduly dismissing alternative therapies and chronic Lyme disease. The investigation was closed on May 1, 2008,

title: Richard Blumenthal
text: Connecticut retained the right to sue L.G. DeFelice for additional funds. In 2009, the bonding company agreed to pay an additional $4.6 million settlement, bringing the total award to $22.1 million ($30,000 more than the repair costs). In November 2006, Blumenthal launched an antitrust investigation into the Infectious Diseases Society of America's (IDSA's) 2006 guidelines regarding the treatment of Lyme disease. Responding to concerns from chronic Lyme disease advocacy groups, Blumenthal claimed the IDSA guidelines would "severely constrict choices and legitimate diagnosis and treatment options for patients." The medical validity of the IDSA guidelines was not challenged, and a journalist